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Forest plotsIntroduction
A systematic literature review can provide a robust answer to a
clinical question by identifying individual studies that provide
evidence relevant to the question and summarising their results. In
the ﬁeld of physiotherapy, systematic reviews commonly summa-
rise the results of randomised trials that test the effect of an
intervention.1 However, systematic reviews can also summarise
studies of the accuracy of diagnostic tests,2 studies of the
prevalence of a clinical condition,3 studies of prognostic factors,4
or other study types. If the included studies are sufﬁciently similar
and the results can be obtained in the same format, ameta-analysis
may be performed.5,6 Meta-analysis is a statistical method used to
summarise numerical data from the individual studies into one
overall estimate. The results of the individual studies and the
overall estimate from the meta-analysis are usually presented in a
graph called a forest plot.
What is a forest plot?
Although forest plots have been used since the 1970s,7 the
name ‘forest plot’ was ﬁrst used in 2001.8 The name refers to the
forest of lines produced when the results of multiple individual
studies are plotted against the same axis. The Cochrane
Collaboration’s ofﬁcial deﬁnition9 states: ‘A forest plot is a
graphical representation of the individual results of each study
included in a meta-analysis together with the combined meta-
analysis result. The plot also allows readers to see the heterogene-
ity among the results of the studies.’ The forest plot provides a
quick visual representation of overall effect estimates and study
heterogeneity and is therefore considered to be a very powerful
tool in meta-analysis.5,6[(Figure_1)TD$FIG]
Cueing Control
Study mean SD Total    mean SD Total
Almeida 2012 6    19 28         1    27   14
de Bruin 2010 3    22    11        −2    17   11
Haase 201 −5    26   17          5    20    6
Mak 2008 5      6   19          0     6   14      
Nieuwboer 2007 8    16   76          2   23   77
Thaut 1996 16    22   15         −5   27   11
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Heterogeneity: Tau2 = 0.00; Chi2 = 4.75, df = 5 (p = 0.45); I2 = 0%
Test for overall effect: Z = 3.01 (p = 0.003)
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Figure 1. Meta-analysis of trials of the effect of cueing versus no cueing on gait speed
A negative mean gait speed means a slower overall gait speed, SD = standard deviation,
Modiﬁed from the systematic review by Tomlinson and colleagues.10
http://dx.doi.org/10.1016/j.jphys.2014.06.021
1836-9553/ 2014 Australian Physiotherapy Association. Published by Elsevier B.V. AlForest plots of randomised trials
Continuous measures of treatment outcome
The forest plot presented in Figure 1 was generated using data
from a systematic review of randomised controlled trials of
rhythmic cueing to improve walking speed in people with
Parkinson’s disease.10 The ﬁrst column (on the left) lists the studies
included in themeta-analysis. Next are three columnsof data for the
experimental group ineachstudy: themeanwalking speed (incm/s),
the standard deviation (to indicate howmuchwalking speed varied
among the participants) and the number of participants. The same
three columnsofdataare thenpresented for the control group. These
data are then used to generate a mean difference in walking speed
(still in cm/s)betweenthegroups for each study. In theﬁrst study, for
example, walking speed improved by a mean of 6 cm/s in the
experimental group and 1 cm/s in the control group. The mean
difference is therefore 6 minus 1 = 5 cm/s. This is presented
numerically and also graphically by plotting a blue square over
the horizontal line. Blue squares to the right of the vertical line
indicate that the study favoured cueing, whilst those to left favour
control. Note that a 95% CI is presented in both the numerical
presentation (by two numbers in parentheses) and the graphical
display (by a horizontal black line). Conﬁdence intervals have been
discussed previously in this journal.11,12 Brieﬂy, each study provides
an estimate of the true effect of cueing on gait speed in people with
Parkinson’s disease. If any of the studies were repeated, a slightly
different resultwould be expected. Loosely speaking, the conﬁdence
interval indicates the range within which the true effect of cueing
probably lies. The estimate from each study is plotted, with the
vertical line presenting the line of no effect. The size of the squares
denotes theweight given to the study, with larger squares reﬂectingMean difference
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(cm/s) in people with Parkinson’s disease, using a random-effect model.
total = number of participants. Test for heterogeneity: chi2 = 4.75, I2 = 0%, p = 0.45.
l rights reserved.
Appraisal Research Note 171more weight. The weight given to each study is automatically
calculated based on the precision of the study’s estimate (precise
estimates receivemoreweight). All the individual estimates are then
statistically pooled using meta-analysis to produce an overall
estimate. This is presented graphically as a black diamond, where
the centre of thediamond is theoverall estimateand thewidthof the
diamond is the overall conﬁdence interval. The pooled estimate is
also presented numerically.
The format of the forest plot presented in Figure 1 would be
suitable for other continuous outcomes, such as activities of daily
living or quality of life, where higher values are better. For
continuous outcomes where lower values are better (such as pain
intensity), values to the left of the vertical line would favour the
experimental group. Also, the studies in Figure 1 all reported gait
speed in more or less the same way and reported the results in
cm/s, so these units can be retained throughout the analysis. If
instead the group of studies had measured an outcome using a
variety of tests (such as different scales for depression), the data
could still be pooled, but each result would be reported as a
standardised mean difference (SMD). To calculate the SMD, the
data in the original units are divided by the standard deviation.
This presents the size of the treatment effect independent of
the scale used. Commonly, effect sizes below 0.3 are considered to
be small, above 0.5 are considered to be moderate, and above 0.8
are considered to be large. However, these thresholds can be
misleading if they are not interpreted in relation to the standard
deviation of the study population.
Dichotomous measures of treatment outcome
Although forest plots for dichotomous outcomes are similar to
those for continuous outcomes, some differences in format are
required. The forest plot presented in Figure 2 is from a systematic
review of trials of surgical techniques in people with chronic neck
pain.13 The outcome assessed in the studies is recovery, so the data
columns now present the number of events (ie, people who had
recovered during the follow-up period) and the total number of
participants. The contrast between groups is now calculated as a
risk difference (ie, the difference in the chance or ‘risk’ of recovery
between the groups) and this is again presented numerically and
graphically. Although Figure 2 shows risk difference, other
statistics can be calculated and meta-analysed for dichotomous
outcomes. One is relative risk, which is the ratio of the probability
of an event in the treated and control groups. Another is the odds
ratio, which is the ratio of the odds of recovery in the treatment
group to the odds of recovery in the control group.[(Figure_2)TD$FIG]
Prosthetic disc Fusion
Study, Year Events  Total      Events  Total
Mummameni 2007 44      276          61      265
Murrey 2009 21      103          23      106
Heller 2009 40      242          53      221
Cheng 2009 6        31          10        34
Jawahar 2010 20       59            9        34
Coric 2011 20     136          39      133
Total (95% CI) 847 793
Total events               151                   195
Heterogeneity: Tau2 = 0.00; Chi2 = 5.64, df = 5 (p = 0.34); I2 = 11%
Test for overall effect: Z = 3.23 (p = 0.001)
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Figure 2.Meta-analysis of trials of the effect of prosthetic disc versus cervical fusion on re
the Mantel-Haenszel method. Test for heterogeneity: chi2 = 5.64, I2 = 11%, p = 0.34.
Modiﬁed from the systematic review by Verhagen and colleagues.13Interpreting forest plots
Statistical signiﬁcance
When a conﬁdence interval includes the vertical line of no
effect, the result is statistically non-signiﬁcant. This is evident
graphicallywhen the horizontal black line (for an individual study)
or the black diamond (for the pooled estimate) crosses the vertical
line of the forest plot. Therefore, the pooled estimate in Figure 1 is
statistically signiﬁcant but several of the individual studies are not.
This illustrates the ability of meta-analyses to harness the
statistical power of multiple studies to produce a more precise
overall estimate, as shown by the narrower conﬁdence interval of
the pooled estimate than the individual studies.
Analysis of subgroups
Individual studies in a forest plot can be arranged in groups
according to a characteristic of the patient population, interven-
tion or follow-up. The estimate of the treatment effect in each
subgroup can be compared to the overall effect estimate. Figure 3
presents a hypothetical subgroup analysis according to the age of
participants. Subgroup differences can occur by chance, so a test
for subgroup heterogeneity is presented. Subgroup differences
can occur even when the test for heterogeneity does not indicate
heterogeneity.
Another way that forest plots can reveal the relationship
between the treatment effect and a characteristic of the
participants, interventions or assessment is to place the studies
on a vertical axis that shows the range of that characteristic.
A forest plot with an extra vertical axis locating each study by
a characteristic on a continuous scale (eg, the gender ratio of the
participants, the duration of the intervention, or the time of
assessment) is called a modiﬁed forest plot.14
Clinical relevance
Sometimes, an additional vertical line is added to the forest plot,
indicating the threshold for clinical relevance; that is, the effect
that is large enough to justify the cost, risks and inconvenience of
the intervention. A hypothetical example of this is shown by the
red dotted line in Figure 3. The location of the conﬁdence interval
in relation to this line and the line of no effect shows how it should
be interpreted. The effect in children is statistically non-signiﬁcant,
whereas the other subgroups all show a statistically signiﬁcant
effect because their conﬁdence intervals are all to the right of the
line of no effect. Among the subgroups with a statisticallyFavours prosthetic disc     Favours fusion
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Figure 5. Forest plot of three studies of the intra-rater reliability of the Berg Balance
Scale.
Modiﬁed from the systematic review by Downs and colleagues.2
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Figure 3. Hypothetical meta-analysis of trials, using a random-effects model, with
subgrouping by age categories. Dotted vertical line represents the threshold for
clinical relevance. Test for heterogeneity: I2 = 67%, p = 0.04.
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Figure 4. Forest plot of eight studies of the prevalence of depression among people
with chronic obstructive pulmonary disease.
Modiﬁed from the systematic review by Zhang and colleagues.3
Appraisal Research Note172signiﬁcant effect, the effect in adolescents is clearly not worth-
while because the conﬁdence interval is below the threshold for
clinical relevance. The effect in adults may or may not be clinically
worthwhile because the conﬁdence interval crosses the threshold.
The effect in the elderly is clearly worthwhile.
Heterogeneity
Heterogeneity refers to variability between studies and can
affect the ability to combine the data of the individual studies.
There are two types of heterogeneity: clinical heterogeneity and
statistical heterogeneity. Clinical heterogeneity refers to the
variability caused by differences in clinical variables, such as the
patient population, interventions, outcome measures or setting of
the included studies. Clinicians determine clinical heterogeneity,
which means that it will always be a rather subjective decision.
Readers should also consider these differences and subjectively
decide whether the clinical heterogeneity is small enough for
meta-analysis to be appropriate. Statistical heterogeneity is the
variability in effect estimates between the studies and can be
quantiﬁed by various statistics. Forest plots only present the
statistical heterogeneity. The simplest statistic is the I2, which
quantiﬁes the heterogeneity from 0 to 100%. There is no clear cut-
point beyond which there is too much heterogeneity. Some use a
rule of thumb stating that around 25% is low heterogeneity,
around 50% medium and around 75% high heterogeneity.15
Although other statistics, such as the Tau2 or chi,2 are sometimes
used, the I2 does not suffer from some of the drawbacks of these
other tests.15
Because forest plots provide a visual representation of study
estimates, another approach is to simply view the variation
between studies and judge the presence of heterogeneity
(‘eyeball’ analysis). This subjective assessment of heterogeneityhas high reproducibility (intra-class correlation = 0.87) and has a
signiﬁcant association with the presence of heterogeneity, as
assessed by a statistical test,7 suggesting this is a reasonable
approach.
Forest plots of other study types
Prevalence studies
Estimates of the prevalence of a clinical condition from
multiple observational studies can also be summarised in a
forest plot. The individual and pooled estimates of prevalence
and their conﬁdence intervals are presented in a similar
way to the forest plots discussed earlier. However, the
estimates are plotted over the x-axis, which extends from 0
(no members of the population have the condition) to 1
(all members of the population have the condition). An example,
which is summarising studies of the prevalence of depression
among people with chronic obstructive pulmonary disease,3 is
presented in Figure 4. Note that the conﬁdence intervals are
symmetrical around prevalence estimates near 0.5, but they
become increasingly asymmetrical as the estimates approach
0 or 1.
Reliability studies
Multiple reliability studies can also be presented on a forest
plot. The example shown in Figure 5 is derived from a systematic
review of reliability studies of the Berg Balance Scale.2
The example summarises intra-rater reliability, with uniformly[(Figure_5)TD$FIG]
[(Figure_6)TD$FIG]
Study TP FP        FN TN Sensitivity Specificity Sensitivity Specificity
Firooznia 1984 97 4 8 7 0.92 (0.86 to 0.97) 0.64 (0.31 to 0.89)
Forristall 1988 20 2 4 5 0.83 (0.63 to 0.95) 0.71 (0.29 to 0.96)
Jackson 1989 I 89       25 36         81 0.71 (0.62 to 0.79) 0.76 (0.67 to 0.84)
Jackson 1989 II 35 8         24         53 0.59 (0.46 to 0.72) 0.87 (0.76 to 0.94)
Schaub 1989 13 6 5 5 0.72 (0.47 to 0.90) 0.45 (0.17 to 0.77)
Schipper 1987         140 7         57         31 0.71 (0.64 to 0.77) 0.82 (0.66 to 0.92)
Thornbury 1993 17 5 1 9 0.94 (0.73 to 1.00) 0.64 (0.35 to 0.87)
0.20 0.4 10.6 0.8 0.20 0.4 10.6 0.8
Figure 6. Forest plot of seven studies of the diagnostic accuracy of computer tomography (CT) scan compared to surgery as reference standard in people with low back pain.
TP = true positive, FP = false positive, FN = false negative, TN = true negative.
Modiﬁed from the systematic review by van Rijn and colleagues.16
Appraisal Research Note 173excellent results across all of the studies. Again the x-axis extends
from0 to 1 and the conﬁdence intervals are asymmetrical. The same
review uses exactly the same format for a forest plot of inter-rater
reliability.2
Diagnostic accuracy studies
The forest plots of diagnostic accuracy studies differ from
forest plots of treatment effectiveness because they show a
double plot. The sensitivity and speciﬁcity estimates are
presented together in one graph, as shown in Figure 6. In
diagnostic test accuracy meta-analyses, the data presented
entail true positive, false positive, false negative and true
negative data for each study. Forest plots of diagnostic accuracy
can provide the same information of pooled summary estimates
and test heterogeneity. However, this is not recommended and
therefore the program Review Manager of the Cochrane
Collaboration does not provide this information together with
the forest plots, but shows that in a receiver operating
characteristic (ROC) graph.
Other variations
Forest plots may also report information about the statistical
method used in the meta-analysis. For example, the meta-analysis
in Figure 2 used the Mantel-Haenszel method, but other methods
for dichotomous outcomes include the Inverse Variance method
and the Peto method. Another possible variation in meta-analyses
is whether a ﬁxed-effect model or a random-effects model is used.
Further information about these methods is available in the
Cochrane handbook.17Summary
Forest plots are frequently used in meta-analysis to present the
results graphically. Without speciﬁc knowledge of statistics, a
visual assessment of heterogeneity appears to be valid and
reproducible. Possible causes of heterogeneity can be explored
in modiﬁed forest plots. Forest plots in meta-analyses appear to be
a valid and useful tool to quickly and efﬁciently scan and interpret
the evidence. The expression ‘a picture is worth a thousand words’
certainly expresses the value of forest plots.
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